Melanoma Clinical Trial
Flu Vaccine Responses in the Setting of Melanoma Treatment
Summary
Influenza vaccination is indicated for all adults, but the immunogenicity of vaccination has not been assessed in all situations. We are conducting a prospective unblinded study of influenza vaccine recipients.
Full Description
Influenza vaccination is indicated for all adults, but the immunogenicity of vaccination has not been assessed in all situations. In particular, immune responses following influenza vaccination have not been studied in the setting of advanced melanoma and in the context of various anti-tumor treatments. In this study, we will look at the immune response of subjects receiving vaccination.
Eligibility Criteria
Inclusion Criteria:
adults capable of providing consent
have a diagnosis of locally advanced or metastatic melanoma
Exclusion Criteria:
are allergic to influenza vaccination
have received influenza vaccination within the past 6 months
require prednisone, methotrexate, or other immunosuppressing medications
have HIV infection
have a history of solid organ or bone marrow transplant
require combination immunotherapy
are on other studies requiring blood draws that might exceed 450 mL total during the period of the influenza vaccine study
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Philadelphia Pennsylvania, 19104, United States
How clear is this clinincal trial information?